PharmaCielo Ltd. (TSXV: PCLO)
Health Care · Pharmaceuticals · CA
CA$0.06
0.00% today · -36.8% 1Y
PharmaCielo Ltd. (TSXV: PCLO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $9.21M and employs 268 people.
Over the last twelve months the share price has lost 36.8%, trading between 0.04 and 0.17.
Tweenvest scores PharmaCielo Ltd. across four factors: quality 8/100, value 70/100, growth 0/100. Its strongest factor is value.
PCLO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.21M
- Revenue (TTM)
- $1.82M
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 0.59
- 52-week high
- CA$0.17
- 52-week low
- CA$0.04
- Avg volume (3M)
- —
- Shares outstanding
- 211.28M
- Employees
- 268
- Next earnings
- —
About PharmaCielo Ltd.
PharmaCielo Ltd., operating in conjunction with its subsidiary, is primarily engaged in the comprehensive cultivation, processing, and distribution of pharmaceutical-grade cannabis extracts, including tetrahydrocannabinol (THC), and associated medicinal products. Additionally, the company diversifies its offerings by providing telemedicine software. Its clientele spans a range of entities, such as health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies, across both Canada and Colombia. PharmaCielo also holds a strategic partnership with AssuredTrans Inc., and its corporate headquarters are situated in Toronto, Canada.
- ISIN
- CA71716K1012
- Listed since
- Mar 4, 2019
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.00 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.38 | +0.54% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.13 | +0.21% |
Figures last refreshed Aug 18, 2026.